PDPK1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.68964842117703E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.14700000000789E-08 |
Normal-vs-Stage2 |
1.48099999996987E-06 |
Normal-vs-Stage3 |
9.43689570931383E-15 |
Normal-vs-Stage4 |
1.62458935193399E-12 |
Stage1-vs-Stage2 |
2.533600E-01 |
Stage1-vs-Stage3 |
7.93980000000083E-05 |
Stage1-vs-Stage4 |
9.70710000047781E-07 |
Stage2-vs-Stage3 |
8.888200E-02 |
Stage2-vs-Stage4 |
8.099700E-03 |
Stage3-vs-Stage4 |
1.878990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.94839757847876E-14 |
Normal-vs-AfricanAmerican |
4.36579994378405E-10 |
Normal-vs-Asian |
2.867400E-01 |
Caucasian-vs-AfricanAmerican |
3.595200E-01 |
Caucasian-vs-Asian |
1.419830E-01 |
AfricanAmerican-vs-Asian |
6.478000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.74849024148216E-12 |
Normal-vs-Female |
7.35439487087319E-11 |
Male-vs-Female |
6.486400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.87269999507578E-09 |
Normal-vs-Age(41-60Yrs) |
7.457900963459E-11 |
Normal-vs-Age(61-80Yrs) |
1.73494552058173E-12 |
Normal-vs-Age(81-100Yrs) |
4.042300E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.718500E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.477000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.121000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.702410E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.928200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.740400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.692300E-02 |
Normal-vs-Grade 2 |
7.46450001809507E-09 |
Normal-vs-Grade 3 |
2.27817764653082E-13 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
2.886000E-01 |
Grade 1-vs-Grade 3 |
5.343700E-02 |
Grade 1-vs-Grade 4 |
4.22070000000163E-05 |
Grade 2-vs-Grade 3 |
2.667600E-02 |
Grade 2-vs-Grade 4 |
3.755600053168E-09 |
Grade 3-vs-Grade 4 |
1.356490E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.46809999995923E-06 |
Normal-vs-ccB subtype |
1.66378022470326E-12 |
ccA subtype-vs-ccB subtype |
1.72643999999389E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.31228361510694E-12 |
Normal-vs-N1 |
4.0713000004633E-07 |
N0-vs-N1 |
1.767020E-01 |
|
|